Sun, Feb 1, 2015, 2:51 PM EST - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

ACADIA Pharmaceuticals Inc. Message Board

  • drmiller355 drmiller355 Nov 27, 2012 12:16 PM Flag

    BASHERS WANT YOUR SHARES CHEAP. NEEDHAM GIVES $9 TARGET. LINK

    The Street insider 11/27
    Needham & Company Upgrades Acadia Pharmaceuticals (ACAD) to Buy
    Article Related Press Releases (2) Related Articles (3) Stock Quotes (1) Comments (0
    Intra-day Needham & Company upgraded Acadia Pharmaceuticals (NASDAQ: ACAD) from Hold to Buy with a price target of $9, following successful top-line results from its pivotal Phase III trial evaluating the efficacy, tolerability and safety of pimavanserin in patients with Parkinson’s disease psychosis.

 
ACAD
30.43-0.62(-2.00%)Jan 30 4:00 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.